RED BANK, N.J., Oct. 29, 2020 /PRNewswire/ -- Provention
Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to
intercepting and preventing autoimmune disease, today announced
that it will report its third quarter 2020 financial results
on Thursday, November 5, 2020.
In connection with the earnings release, Provention's management
team will host a live conference call and webcast at 8:00 AM
ET on Thursday, November 5, 2020, to discuss the
Company's financial results and provide a business update.
Conference Call and Webcast Information:
To access the call, please dial 1-(866)-682-6100 (domestic) or
1-(862)-298-0702 (international) ten minutes prior to the start
time and ask to be connected to the "Provention Bio Call." An audio
webcast will also be available on the "Events and Webcasts" page of
the Investors section of the Company's
website, www.proventionbio.com. An archived webcast will
be available on the Company's website approximately two hours after
the conference call and will be available for seven days following
the call.
About Provention Bio, Inc.:
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical
company focused on advancing the development of investigational
therapies that may intercept and prevent debilitating and
life-threatening immune-mediated disease. The company's lead
investigational drug candidate, teplizumab, is currently under
review by FDA for the delay or prevention of insulin-dependent type
1 diabetes (T1D) in at-risk patients during the pre-symptomatic
phase of the disease. The Company's pipeline includes additional
clinical product development candidates that have
demonstrated in pre-clinical or clinical studies
proof-of-mechanism and/or proof-of-concept in other autoimmune
diseases, including celiac disease and lupus.
Visit ProventionBio.com for more information or follow us
on Twitter: @Proventiobio
Investor Contact:
Sam Martin, Argot Partners
sam@argotpartners.com
212-600-1902
Media:
Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-report-third-quarter-2020-financial-results-and-host-conference-call-on-thursday-november-5-2020-301162630.html
SOURCE Provention Bio, Inc.